HBV mutation literature information.


  Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates.
 PMID: 18036224       2007       BMC microbiology
Discussion: This triple mutant is known to exhibit reduced in vitro affinity for anti-HBs antibodies, similar to the hepatitis B vaccine escape mutant G145R.


  [Algorithm of serologic screening and assessment of prevalence of serologically meaningful mutations of HBsAg in hepatitis B virus carriers].
 PMID: 18283732       2007       Zhurnal mikrobiologii, epidemiologii i immunobiologii
Abstract: Analysis of primary nucleotide sequence revealed serologically meaningful mutations in S-gene of HBV in all 9 isolates: 3 of them contained substitution mutation G145R, 5--S143L, and one--T143M.
Abstract: Prevalence of HBsAg mutations in HBV carriers with high level of HBsAg was assessed for the first time: prevalence of G145R, S143L/T143M mutations, and all serologically atypical variants was 0.12%, 0.24%, and 0.76% respectively.


  Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers.
 PMID: 16299725       2006       Journal of medical virology
Abstract: Other substitutions, including Gly145Arg (0.4%), were found at a frequency of less than 1%.


  Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
 PMID: 16299727       2006       Journal of medical virology
Abstract: Mutations in the major hydrophilic loop (MHL) of the S gene region were also detected, including the 'vaccine escape' mutation G145R in three cases.


  Characteristics of hepatitis B virus in Ghana: full length genome sequences indicate the endemicity of genotype E in West Africa.
 PMID: 16372296       2006       Journal of medical virology
Abstract: Of note, the finding of the G145R escape mutant in an unvaccinated Ghanaian blood donor might raise concern as to the ongoing nation-wide hepatitis B vaccination program in Ghana.


  Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.
 PMID: 16419112       2006       Journal of medical virology
Abstract: Sequencing of HBV isolates revealed that mutations including G145R and stop codons occurred within the HBsAg coding region.


  "HBsAg diagnostic kits in the detection of hepatitis B virus mutation within ""a"" determinant."
 PMID: 16553556       2006       Viral immunology
1Abstract: Interestingly, any commercial kits with monoclonal antibody capture and polyclonal antibody detection (mono/poly), but not mono/mono Ab capture and detection, could pick up the common HBsAg Gly145Arg mutant either solely or in combination with other mutations within the ""a"" determinant."


  Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
 PMID: 16567005       2006       Journal of virological methods
Abstract: The VIDAS HBsAg Ultra (L) did not detect one diluted sample out of six bearing the single aa G145R substitution, and two out of 12 diluted samples harbouring multiple aa substitutions.


  Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene.
 PMID: 16622880       2006       Journal of medical virology
Abstract: However, they do not guarantee full sensitivity, especially for the detection of the G145R mutation and amino acid insertions or substitutions in positions 120-123.
Abstract: There is also a need for more complete epidemiological data on the prevalence of HBsAg mutants especially for G145R and assays for the (differential) screening of mutants need to be developed and evaluated.


  Infections by hepatitis B surface antigen gene mutants in Europe and North America.
 PMID: 16622882       2006       Journal of medical virology
Abstract: In some cases, these mutations have included a glycine to arginine substitution at position 145 (G145R), which results in a conformational change and different reactivity to monoclonal antibody reagents than that of the wild-type virus.
Abstract: Mutations in the a determinant (but not G145R) also have been reported in European patients with chronic HBV infection who have not received HBV vaccine or HBIG.



Browser Board

 Co-occurred Entities




   Filtrator